Skip to main content
. 2018 Nov 15;8(12):484. doi: 10.1007/s13205-018-1500-z

Fig. 2.

Fig. 2

Verifying insertion of camelied anti-VEGFR2 nanobody in TuMv vector. PCR amplification of anti-VEGFR2 nanobody; C−: negative control (TuMv-GFP), C+: positive control, Lanes 1–4: bacteria colonies, molecular weight marker (1 kb standard GeneRuler)